“We took a prudent approach with this deal, as we had done with our AT1 from last summer, now completing our full capital needs for the next five years, assuming no change on the risk weighted assets, ...

Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Axsome Therapeutics in a research note issued to investors on Thursday, February 20th. HC Wainwright analyst R ...

By Ben Aris in Berlin Russian President Vladimir Putin has opened the door to Western companies’ return to the Russian market ...

William Blair cut their Q1 2025 earnings per share estimates for Axsome Therapeutics in a report issued on Tuesday, February ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 10, 2024. REUTERS/Brendan McDermid/File Photo U.S. stocks tumbled on Friday, extending their ...